Government policy interventions have not been rigorously evaluated to fight the growing threat of antimicrobial resistance, revealed new study published this week in PLOS Medicine by Susan Rogers Van Katwyk of the University of Ottawa, Canada, and colleagues.
In the new work, researchers systematically searched seven global databases for studies that clearly described and evaluated a government policy intervention aimed at reducing human antimicrobial misuse. They identified 69 published evaluations of such interventions carried out around the world.
Standardized Protocols to Tackle Antimicrobial Resistance
Experts define global criteria for hospital programs to tackle antimicrobial resistance.
Advertisement
‘Antimicrobial resistance (AMR) is on the rise due to persistent misuse and overuse of antimicrobials, and has already rendered some infections untreatable with existing drugs.’
Tweet it Now
Described in these 69 studies were 17 different types of policies that governments have deployed and tested to reduce antimicrobial use, including public awareness campaigns, antimicrobial guidelines, vaccination, and tailored regulations for prescribing and reimbursement. Unfortunately, most existing policy options have not been rigorously evaluated, which limits their usefulness in planning future policy interventions. Of the studies, only 4 had a randomized controlled design, the gold standard for medical interventions, while 35 used rigorous quasi-experimental designs and the remaining 30 were uncontrolled and descriptive. The current systematic review was unable to directly investigate the impact of the different interventions on AMR, but reductions in antimicrobial use are likely to lead to lower levels of resistance over time.
"To avoid future waste of public resources, and in line with WHO recommendations for national action on AMR, governments should ensure that AMR policy interventions are evaluated using rigorous study designs and that study results are published," the authors say.
Source: Eurekalert
Source: Eurekalert
ICMR Partners With Pfizer to Set Up Center to Combat Antimicrobial Resistance
The Indian Council of Medical Research has signed a MoU with the American pharmaceutical firm Pfizer to set up a center to combat antimicrobial resistance.
Advertisement
 Antimicrobial Resistance is Increasing TremendouslyAiming at reining in antimicrobial resistance (AMR), the Indian Medical Association (IMA) has come out with a draft policy on use of antibiotics in healthcare. | Advertisement
|
Challenges in Tackling the Growing Problem of Antimicrobial Resistance
Researchers sequenced genomes to uncover the origins of the very first MRSA to trace its evolutionary history.
Advertisement
Recommended Reading
Latest Research News
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.